ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "COVID-19"

  • Abstract Number: 1280 • ACR Convergence 2020

    COVID-19 Infections May Increase the Risk of SLE Flares

    Leila Khalili1, Yevgeniya Gartshteyn2, Nancyanne Schmidt3, Teja Kapoor4, Laura Geraldino-Pardilla5 and Anca Askanase3, 1Columbia University Medical Center, New York, NY, 2Columbia University College of Physicians and Surgeons, Glen Rock, NJ, 3Columbia University College of Physicians and Surgeons, New York, NY, 4Columbia University College of Physicians and Surgeons, Leonia, NJ, 5Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York

    Background/Purpose: COVID-19 has overwhelmed the healthcare systems in New York City. Initial data from the Columbia Lupus Cohort suggests that 4% of patients with systemic…
  • Abstract Number: 1686 • ACR Convergence 2020

    The COV-ASAKI Survey from the Pediatric Tuscany Network During COVID-19 Era

    Maria Vincenza Mastrolia1, Rino Agostiniani2, Chiara Azzari3, Roberto Bernardini4, Ugo Bottone5, Giovanni Battista Calabri6, Flavio Civitelli7, Rita Consolini8, Roberto Danieli9, Rosalia Di Silvio10, Susanna Falorni11, Luigi Gagliardi12, Salvatore Grosso13, Marco Martini14, Graziano Memmini15, Marco Pezzati16, Giovanni Suriano17, Luca Tafi18, Angelina Vaccaro19, Pier Luigi Vasarri20 and Gabriele Simonini21, 1Rheumatology Unit, Meyer Children's University Hospital, Firenze, Italy, Florence, Toscana, Italy, 2Paediatric Unit, San Jacopo Hospital, Pistoia, Italy, Pistoia, Toscana, Italy, 3Paediatric Immunology Unit, Department of Health Sciences, Meyer Children’s University Hospital, Firenze, Italy, Florence, Toscana, Italy, 4Paediatric Unit, San Giuseppe Hospital, Empoli, Italy, Empoli, Toscana, Italy, 5Division of Neonatology and Pediatrics, Lotti Hospital, Pontedera, AUSL Toscana Nord Ovest, Pisa, Italy, Pisa, Toscana, Italy, 6Cardiologic Unit, Meyer Children’s University Hospital, Firenze, Italy, Florence, Toscana, Italy, 7Division of Neonatology and Pediatrics, Montepulciano Hospital, Montepulciano, AUSL Sud Est Toscana, Siena, Italy., Siena, Toscana, Italy, 8Section of clinical and laboratory Immunology, Department of clinical and experimental Medicine, University of Pisa, Italy, Pisa, Italy, 9Division of Neonatology and Pediatrics, Spedali Riuniti di Livorno, Livorno, AUSL Toscana Nord Ovest, Pisa, Italy, Livorno, Toscana, Italy, 10Paediatric Unit, Mugello Hospital, Borgo San Lorenzo, Firenze, Italy, Florence, Toscana, Italy, 11Paediatric Unit, Misericordia Hospital, Grosseto, Italy, Grosseto, Italy, 12Division of Neonatology and Pediatrics, Ospedale Versilia Hospital, Viareggio, AUSL Toscana Nord Ovest, Pisa, Italy, Viareggio, Toscana, Italy, 13Clinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy, Siena, Toscana, Italy, 14Paediatric Unit, San Donato Hospital, Arezzo, Italy, Arezzo, Toscana, Italy, 15Division of Neonatology and Pediatrics, Apuane Hospital, Massa Carrara, AUSL Toscana Nord Ovest, Pisa, Italy, Massa Carrara, Toscana, Italy, 16Paediatric Unit, Santa Maria Annunziata Hospital, Bagno a Ripoli, Firenze, Italy, Florence, Toscana, Italy, 17Division of Neonatology and Pediatrics, Cecina Hospital, Cecina, AUSL Toscana Nord Ovest, Pisa, Italy, Cecina, Toscana, Italy, 18Paediatric and Neonatal Unit, Valdarno Hospital, Montevarchi, Arezzo, Italy, Arezzo, Toscana, Italy, 19Division of Neonatology and Pediatrics, San Luca Hospital, Lucca, AUSL Toscana Nord Ovest, Pisa, Italy, Lucca, Toscana, Italy, 20Paediatric and Neonatologic Unit, Santo Stefano Hospital, Prato, Italy, Prato, Toscana, Italy, 21Rheumatology Unit, Meyer Children's University Hospital, Florence; NEUROFARBA Department, University of Florence, Italy, Florence, Italy

    Background/Purpose: At the end of April 2020, national and international Pediatrics scientific societies diffused an alert about a rise in the number of pediatric severe,…
  • Abstract Number: 0017 • ACR Convergence 2020

    Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications

    Daniel Watrous1, Glenn Parris2, Priya Reddy3, Jeffrey Alper4, Fenglong Xie5, Maria (Maio) Danila6, Michael George7, William Nowell8, Joel Kallich9 and Jeffrey R Curtis10, 1Sierra Pacific Arthritis, Visalia, CA, 2PARRIS & ASSOCIATES, Lilburn, GA, 3Southwest Florida Rheumatology, Riverview, FL, 4Medallion Clinical Research Institute, LLC, Naples, FL, 5University of Alabama at Birmingham, Birmingham, AL, 6University of Alabama at Birmingham (UAB), Birmingham, AL, 7University of Pennsylvania, Philadelphia, PA, 8Global Healthy Living Foundation, New York City, NY, 9Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, 10Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The global COVID19 pandemic has had a major impact on healthcare. The effect on rheumatology patients and providers is unclear, as is the role…
  • Abstract Number: 0442 • ACR Convergence 2020

    Disparities in CoronaViridae Infection Are Readily Apparent in Rheumatology Patients Despite Use of Hydroxychloquine And/or Methotrexate

    Maria Antonelli1 and Nora Singer2, 1MHMC/CWRU, Cleveland, OH, 2The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: In the initial months of the SARS CoV2/COVID19 pandemic, broad use of off-label therapy with hydroxychloroquine (HCQ) was prescribed to reduce CoV2-related morbidity and…
  • Abstract Number: 0597 • ACR Convergence 2020

    Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience

    Y. Ingrid Goh1, Nancy Pan2, Julia Harris3, Andrew Warmin4, Janalee Taylor4, Sheetal Vora5, Fatima Barbar-Smiley6, Jon Burnham7, Tzielan Lee8, Cagri Yildirim-Toruner9, Kendra Wiegand10 and Esi Morgan11, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Special Surgery, New York, NY, 3Children's Mercy Kansas City, Overland Park, KS, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Atrium Health Levine Children's Hospital, Charlotte, NC, 6Nationwide Children's Hospital/The Ohio State University, Columbus, OH, 7Children's Hospital of Philadelphia, Philadelphia, PA, 8Stanford University School of Medicine, Palo Alto, CA, 9Nationwide Children's Hospital, Houston, TX, 10Cincinnati Children's Hospital, Cincinnati, 11Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Healthcare teams were forced to rethink the way they practiced medicine during the COVID-19 pandemic. Many teams transitioned from conducting in-person visits to virtual…
  • Abstract Number: 0640 • ACR Convergence 2020

    Covid-19 and Rheumatic and Musculoskeletal Disease Patients: Infection Rates, Attitudes and Medication Adherence

    Kieran Murray1, Sean Quinn2, Matthew Turk2, Anna O'Rourke3, Eamonn Molloy1, Lorraine O'Neill4, Anne Mongey5, Ursula Fearon6 and Douglas Veale7, 1Saint Vincent's University Hospital, Dublin 4, Dublin, Ireland, 2Saint Vincent's University Hospital, Dublin 4, Ireland, 3Saint James' University Hospital, Dublin 6, Ireland, 4Saint Vincent's University Hospital, Dublin, Ireland, 5Saint Vincent's University Hospital, Co Dublin, Ireland, 6Molecular Rheumatology, Trinity College Dublin, Dublin, Dublin, Ireland, 7EULAR Centre for Arthritis and Rheumatic Diseases, St Vincents University Hospital, UCD, Dublin, Dublin, Ireland

    Background/Purpose: Covid-19 has caused >400,000 deaths. The relationship between RMDs, immunosuppressive medications and Covid-19 is unclear. This study explores Covid-19 prevalence, DMARD adherence, information sources…
  • Abstract Number: 1301 • ACR Convergence 2020

    Characterizing How SLE Patients Access Health Information Pre and During COVID-19

    Francesca Cardwell1, Susan Elliott2, May Choi3, Ricky Chin4 and Ann Clarke5, 1University of Waterloo, Burlington, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5University of Calgary, Calgary, Canada

    Background/Purpose: The spread of misinformation related to COVID-19 has been especially acute for SLE patients as unsubstantiated claims regarding the efficacy of antimalarials for COVID-19…
  • Abstract Number: 1769 • ACR Convergence 2020

    Patient-reported COVID-19 Infection in Pregnant Women with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance Patient Experience Survey

    Jonathan Hausmann1, Emily Sirotich2, Bonnie Bermas3, Megan Clowse4, Milena Gianfrancesco5, Pedro M Machado6, Helen Robinson7, Anja Strangfeld8, Jinoos Yazdany9 and Philip Robinson10, 1Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 2McMaster University, Hamilton, ON, Canada, 3UTSouthwestern.edu, Dallas, TX, 4Duke University, Chapel Hill, NC, 5University of California, San Francisco, San Francisco, CA, 6University College London, London, United Kingdom, 7University of Queensland School of Medicine, HERSTON, Queensland, Australia, 8German Rheumatism Research Center, Berlin, Germany, 9UCSF, San Francisco, CA, 10University of Queensland, Herston, Queensland, Australia

    Background/Purpose: The impact of COVID-19 on pregnancy in patients with rheumatic disease is unknown.  We describe COVID-19 outcomes in pregnant women with rheumatic disease who…
  • Abstract Number: 0018 • ACR Convergence 2020

    PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City

    Gregory Vitone1, Marianna Frey2, Candace Feldman3, Lindsay Lally2, Anne Bass4, Jane Salmon2, Mary Crow2, Michael Lockshin5, Vivian Bykerk2, Medha Barbhaiya5 and Lisa Mandl2, 1Hospital for Special Surgery, New York, 2Hospital for Special Surgery, New York, NY, 3Brigham and Women's Hospital, Boston, MA, 4Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Hospital for Special Surgery, Barbara Volcker Center for Women and Rheumatic Diseases, New York, NY

    Background/Purpose: Little is known about the general health and wellbeing of patients with systemic rheumatic diseases (SRD) during the COVID pandemic.  We sought to compare…
  • Abstract Number: 0443 • ACR Convergence 2020

    Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed with Rheumatic Diseases

    Emily Sirotich1, Teresa Semalulu1, Kevin Kennedy2, Salman Surangiwala3, Maggie Larche1, Jean Liew4, Mitchell Levine2, Graeme Reed5, Naira Ikram6, Carly Harrison7, Richard Howard8, Rashmi Sinha9, Monique Gore-Massy10 and Jonathan Hausmann11, 1McMaster University, Hamilton, ON, Canada, 2McMaster University, Hamilton, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4University of Washington, Seattle, 5Canadian Spondylitis Association, Vancouver, Canada, 6Duke University, Durham, 7Lupus Chat, NA, 8Spondylitis Association of America, Van Nuys, CA, 9SJIA Foundation, Cincinnati, 10Lupus Foundation of America, Brooklyn, NY, 11Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA

    Background/Purpose: The COVID-19 pandemic has exacerbated structural and systematic barriers in access to healthcare for racial and ethnic minorities. The impact of these increased barriers…
  • Abstract Number: 0599 • ACR Convergence 2020

    Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic

    Ulrich Drott1, Axel Braner1, Thomas Kollewe2, Harald Burkhardt3 and Florian Meier1, 1Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt, Germany, 2J. W. Goethe-Universität Frankfurt, FB Medizin, Frankfurter Arbeitsstelle für Medizindidaktik, Frankfurt, Germany, Frankfurt, Germany, 3Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt am Main, Germany

    Background/Purpose: The Covid-19 pandemic holds multiple challenges for the healthcare system. Quick adoptions and adjustments are the mainstays during these times. Hygiene management and plans…
  • Abstract Number: 0641 • ACR Convergence 2020

    Cohort of Rheumatic Patients Treated with Rituximab and COVID-19: Does Rituximab Treatment Increases the Severity of SARS-COV2 Infection?

    Antía García-Fernández1, Fernando López-Gutiérrez1, Jesús Loarce-Martos1, Ivan Del Bosque-Granero2, Laura Calvo-Sanz1, Boris Blanco-Cáceres1, Cristina Pijoan-Moratalla1, Lourdes Villalobos-Sánchez3, Javier Bachiller-Corral1 and Mónica Vázquez1, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain, 3Rheumatology, Hospital Universitario Ramón y Cajal, Madrid

    Background/Purpose: There are very few studies reporting COVID-19 in patients with rheumatic diseases, without clear evidence supporting more frequent or severe disease in these patients.…
  • Abstract Number: 1339 • ACR Convergence 2020

    COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

    Rebecca Haberman1, Rochelle Castillo1, Alan Chen2, Di Yan1, Deborah Ramirez2, Vaish Sekar2, Robert Lesser2, Gary Solomon2, Andrea Neimann2, Rebecca Blank1, Peter Izmirly3, Dan Webster4, Alexis Ogdie5, Andrea Troxel2, Samrachana Adhikari2 and Jose Scher1, 1NYU School of Medicine, New York City, 2NYU Langone Health, New York City, 3New York University, New York, NY, 4Sage Bionetworks, Seattle, 5Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The COVID-19 pandemic has quickly emerged as the most challenging global health crisis in a generation. Affecting initially China, New York City (NYC) quickly…
  • Abstract Number: 1783 • ACR Convergence 2020

    Experience of Pregnant Rheumatology Outpatients from a Tertiary Hospital in New York City During the COVID-19 Pandemic

    Bessie Stamm1, Gregory Vitone2, Marianna Frey3, JoAnn Vega1, Jane Salmon3, Mary Crow3, Vivian Bykerk3, Michael Lockshin1, Lisa Sammaritano1, Lisa Mandl3 and Medha Barbhaiya1, 1Hospital for Special Surgery, Barbara Volcker Center for Women and Rheumatic Diseases, New York, NY, 2Hospital for Special Surgery, New York, 3Hospital for Special Surgery, New York, NY

    Background/Purpose: We aimed to evaluate the experience of pregnant rheumatology patients during the peak of the COVID-19 pandemic in New York City.Methods: We emailed a…
  • Abstract Number: 0019 • ACR Convergence 2020

    Lasting COVID-19 Impacts on US Rheumatology Practices

    Lynn Price1, Gianna Melendez1 and Phil Pouliot1, 1spherix global insights, Exton, PA

    Background/Purpose: In late 2019, a novel, highly contagious coronavirus (COVID-19), was discovered in China and quickly spread throughout the world, equating to arguably the largest…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology